echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The Nature subjournal identified gene therapy targets for polycystic kidney disease

    The Nature subjournal identified gene therapy targets for polycystic kidney disease

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Image: This image shows a severe cystic kidney from a mouse model of ADPKD (left



    Researchers at the University of Texas at Southwestern report that blocking inhibition of PKD1 and PKD2 gene expression by deleting binding sites of microRNAs can hinder the formation and growth


    "For 25 years, we have known that ADPKD is caused


    ADPKD is one of the most common human genetic diseases and the most common genetic cause of kidney failure, affecting approximately 12.


    Proteins are produced (or translated) by the gene's messenger,


    PKD1 contains the binding site of miR-17, a microRNA


    The researchers removed the miR-17 binding site


    "In many genetic conditions, one copy of the gene is mutated, but the other copy is still normal


    The University of Texas Southwestern opened the PKD and Genetic Nephropathy Clinic in 2016, co-led


    Other researchers who contributed to the study include Patricia copo - stark, Laurence Biggers, Andrea Flaten and Jesus Alvarez, all from UTSW; Chunmin Zhang, Tania Valencia, Darren P.


    This work was supported by grants


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.